Financial Results with Results Press Release & Limited Review for Sept 30, 2013
Link: Click Here
Outcome of Board Meeting:
Granules India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 30, 2013, inter alia, has decided to close M/s Granules Singapore PTE LTD, wholly owned subsidiary of the Company, located at Singapore.
Granules India eyes Rs 1,000 cr turnover this fiscal
Link: Click Here
Granules capacity utilisation efforts drive Q2 profits
Link: Click Here
The company has declared numbers which very rightly justified the stock performance in past 6 months. If one has observed carefully, in Mar-Apr 13, the stock made a low of 90. From there, it has already doubled in past 6 months. The numbers posted by the company is exactly in line with the high expectations of market.
The Revenues have gone up to 266 Cr from 175.5 Cr last year on consolidated basis, that is growth of 52%.
The Net Profit has gone up to 15.1 Cr from 8.1 Cr last year, that is growth of 87%
Hence, EPS jumps from 4.03 to 7.5.
As nicely pointed out by management, that the total net profit made by the company in FY13, is already made by it in just 2 quarters of this fiscal.
The formulations facility at Gagillapur continued to scale-up production which improved capacity utilization. The company expects a majority of customer approvals to be in place in the second half of the fiscal year.
Granules is expecting at least Rs 50 crore revenue next fiscal from its 50:50 joint venture with Ajinomoto Omnichem, which is setting up the manufacturing plant at Visakhapatnam in Andhra Pradesh. This facility will supply products to the regulated markets such as north America and Europe. The revenue from this venture could reach around Rs 160 crore over the next couple of years when fully operational.
One can go through all the details in links mentioned above.
My Views:
I am very happy with numbers posted by the company. I never judge anything, based on sudden move seen here and there in stock prices in 1-2 days. Today, once the results were out, it immediately made a high of 185, and as soon as the news regarding GIL Singapore came in, the stock saw a low of 169. For me, that is not at all a big event. It wasn't a huge revenue generator for the company. I continue to be a very long term investor over here. It seems nothing wrong, even if one buys the stock at these levels. And a buy on every dips is higly suggested.
I am eagerly waiting for company to deliver Q3 and Q4 results, because, company has been very optimistic about the second half of this fiscal from the beginning. Again, here, I am not setting any targets, would just advice one to buy and hold for long term.
Happy Investing!!!!!
I think there is some confusion with the result dates given by Gulshan Polyols and Suven Life Sciences, as the dates have already gone, and they haven't reported the results to any of the exchanges.
ReplyDeleteSo, we will be waiting for now, and I will post the details, once they are out with numbers.
Gulshan Polyols will be out with numbers on 6th Nov....
ReplyDeleteGoing busy these days, hence will try to come out with post on Cera Sanitaryware by tomorrow or at max day after tomorrow.
ReplyDeleteResults are good. Revenues has grown by around 42%, which is great for company with India based market. Net profit is absolutely flat, and that was the reason for some downside in stock price.
But as always, being a long term investor, we dont care much about net profits if revenues are growing strongly...
V V S Murthy Granules India Ltd CFO Exclusive Interview
ReplyDeleteLink: http://www.hybiz.tv/V-V-S-Murthy-Granules-India-Ltd-CFO/179021
Harsha Chigurupati Granules India Ltd Exclusive Interview
Link: http://www.hybiz.tv/Harsha-Chigurupati-Granules-India-Ltd-/179020